Quality Systems

Latest News


ePT--the Electronic Newsletter of Pharmaceutical Technology

GlaxoSmithKline Consumer Healthcare, Cephalon UK Ltd, and ProStraken Group plc have been accused of breaching the Association of the British Pharmaceutical Industry's (ABPI) Code of Practice.

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Food and Drug Administration and European Medicines Agency (EMA) are looking for drug manufacturing companies to participate in their joint good manufacturing practice (GMP) inspection pilot program.

G3WhiteNit_LR_FWEB-682831-1408628110531.jpg

Equipment and Processing Report

Changing or upgrading cleanroom gloves requires time and due consideration. A good decision could improve employee satisfaction and product yields, but a bad decision could necessitate millions of dollars worth of rework, recalls, and rejects if the gloves don?t perform as expected. Personnel should consider various criteria to choose the best glove for their cleanroom.

ePT--the Electronic Newsletter of Pharmaceutical Technology

In a draft guidance published this week, the US Food and Drug Administration recommended that makers of transdermal and transmucosal drug-delivery systems use "an appropriate scientific approach" during product design, development, and manufacturing to minimize the amount of residual drug substance present at the end of the products' labeled use periods.

ePT--the Electronic Newsletter of Pharmaceutical Technology

Legislative efforts to modernize provisions in the Toxic Substances Control Act of 1976 (TSCA), which involve chemical safety and reporting requirements is drawing criticism from the chemical industry.

ePT--the Electronic Newsletter of Pharmaceutical Technology

The Senate Appropriations Committee approved a measure last week that would restrict the use of certain patent settlements by innovator-drug companies under which innovator-drug companies pay generic-drug companies to delay the entry of a generic product in so-called "pay-for-delay" cases.

Turning a Blind Eye

Cases of overlooking proper packaging, reconstitution, directions, and dissolution.

Report from Asia

Manufacturers and regulators on both sides of the ocean move to ensure the safety of heparin and other globally distributed drug products.

i1-681728-1408629063403.jpg

Catalyst for Change

Industry can meet its responsibility to society by considering innovative pricing and partnerships.